TCL Archive Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock December 17, 2013
TCL Archive DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts February 23, 1990
TCL Archive NCAB Jolted By 1977 Prelim Budget, “Outrageous” Prospect – Funding Only 30% Of Approved Grants June 27, 1975
TCL Archive NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection. March 26, 2004
